Lazard Capital Starts Regeneron Pharma (REGN) at Neutral
Tweet Send to a FriendGet Alerts REGN Hot Sheet
Price: $266.97 +0.87%
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade REGN Now!
Lazard Capital initiates coverage on Regeneron Pharma (NASDAQ: REGN) with a Neutral.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $137.45 yesterday, with a 52 week range of $42.83-$145.04.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $137.45 yesterday, with a 52 week range of $42.83-$145.04.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UBS Starts Regeneron Pharma (REGN) at Neutral
- Barclays Starts T-Mobile US, (TMUS) at Equalweight
- Barclays Starts AT&T (T) at Equalweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
